Sort by
Refine Your Search
-
Physician – Internal Medicine, Medical Oncology, Gastrointestinal Oncology (Open Rank/Track Faculty)
at this time are those who desire to focus their research and patient care in GI Oncology. OSU GI Oncology Program Features: 18 dedicated GI oncology focused physicians (9 medical oncologists, 5 surgical
-
) the information in your candidate profile as it will transfer to your application. Job Title: Research Faculty - Computational Psychiatry - Open Rank and Track Department: Medicine | Psychiatry The Ohio State
-
-based care through an interdisciplinary approach. Our mission is to be the premier academic model for inpatient care and faculty development at The Ohio State University and in the Midwest. Our vision is
-
illnesses, serving as an alternative for non-life-threatening emergencies. The Department of Emergency Medicine offers two residency programs. The Emergency Medicine (EM) Residency Program is a three year
-
therapists, dietitians, case managers, and social workers. The SICU is supported in part by a joint surgical critical care and anesthesia critical care fellowship program with six fellows. The SICU has 16
-
fellowships and international training opportunities through the OSU Global Neurology Initiative, with partner programs in Africa, the Middle East, and Latin America. In 2024, our Neurology Residency Program
-
, the team has directed care in the 30-bed cardiovascular surgery intensive care unit (CIVCU). The CVICU is the home for our high-volume ECLS/ECMO and end-stage cardiopulmonary failure program, including a
-
or IM-Peds Residency from an ACGME accredited program; and be board-certified/eligible in Internal Medicine. Fellowship training and/or a track record of independent funding is required. PhD Researchers
-
. Translational Breast Cancer Research Program : This includes tissue/blood sample coordination, research genomic profiling, trial correlative support, and research collaboration opportunities. Pelotonia Institute
-
(ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract Consistently ranked as one of America’s Best